Annual Cash & Cash Equivalents
$13.01 M
-$4.78 M-26.88%
December 31, 2023
Summary
- As of February 8, 2025, SNSE annual cash & cash equivalents is $13.01 million, with the most recent change of -$4.78 million (-26.88%) on December 31, 2023.
- During the last 3 years, SNSE annual cash & cash equivalents has fallen by -$3.58 million (-21.60%).
- SNSE annual cash & cash equivalents is now -26.88% below its all-time high of $17.80 million, reached on December 31, 2022.
Performance
SNSE Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$19.13 M
+$7.24 M+60.89%
September 30, 2024
Summary
- As of February 8, 2025, SNSE quarterly cash and cash equivalents is $19.13 million, with the most recent change of +$7.24 million (+60.89%) on September 30, 2024.
- Over the past year, SNSE quarterly cash and cash equivalents has increased by +$6.12 million (+47.04%).
- SNSE quarterly cash and cash equivalents is now -88.71% below its all-time high of $169.42 million, reached on March 31, 2021.
Performance
SNSE Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
SNSE Cash And Cash Equivalents Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -26.9% | +47.0% |
3 y3 years | -21.6% | +7.5% |
5 y5 years | +1892.5% | +7.5% |
SNSE Cash And Cash Equivalents Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -26.9% | +81.7% | at high | +167.2% |
5 y | 5-year | -26.9% | +5083.7% | -88.7% | +7521.9% |
alltime | all time | -26.9% | +5083.7% | -88.7% | +7521.9% |
Sensei Biotherapeutics Cash And Cash Equivalents History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $19.13 M(+60.9%) |
Jun 2024 | - | $11.89 M(+8.5%) |
Mar 2024 | - | $10.96 M(-15.8%) |
Dec 2023 | $13.01 M(-26.9%) | $13.01 M(+14.7%) |
Sep 2023 | - | $11.34 M(+10.9%) |
Jun 2023 | - | $10.23 M(+26.1%) |
Mar 2023 | - | $8.11 M(-54.4%) |
Dec 2022 | $17.80 M | $17.80 M(+55.4%) |
Sep 2022 | - | $11.45 M(+15.7%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2022 | - | $9.90 M(+13.5%) |
Mar 2022 | - | $8.72 M(+21.8%) |
Dec 2021 | $7.16 M(-56.9%) | $7.16 M(-24.9%) |
Sep 2021 | - | $9.53 M(-38.9%) |
Jun 2021 | - | $15.60 M(-90.8%) |
Mar 2021 | - | $169.42 M(+920.8%) |
Dec 2020 | $16.60 M(+6512.0%) | $16.60 M(+344.6%) |
Sep 2020 | - | $3.73 M(+1387.3%) |
Dec 2019 | $251.00 K(-61.6%) | $251.00 K |
Dec 2018 | $653.00 K | - |
FAQ
- What is Sensei Biotherapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Sensei Biotherapeutics?
- What is Sensei Biotherapeutics annual cash & cash equivalents year-on-year change?
- What is Sensei Biotherapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Sensei Biotherapeutics?
- What is Sensei Biotherapeutics quarterly cash and cash equivalents year-on-year change?
What is Sensei Biotherapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of SNSE is $13.01 M
What is the all time high annual cash & cash equivalents for Sensei Biotherapeutics?
Sensei Biotherapeutics all-time high annual cash & cash equivalents is $17.80 M
What is Sensei Biotherapeutics annual cash & cash equivalents year-on-year change?
Over the past year, SNSE annual cash & cash equivalents has changed by -$4.78 M (-26.88%)
What is Sensei Biotherapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of SNSE is $19.13 M
What is the all time high quarterly cash and cash equivalents for Sensei Biotherapeutics?
Sensei Biotherapeutics all-time high quarterly cash and cash equivalents is $169.42 M
What is Sensei Biotherapeutics quarterly cash and cash equivalents year-on-year change?
Over the past year, SNSE quarterly cash and cash equivalents has changed by +$6.12 M (+47.04%)